Overview
Infective endocarditis involving vascular cardiac conduits, such as synthetic grafts post-transplantation, is a serious complication characterized by infection and inflammation within the graft, potentially leading to thrombosis, stenosis, and graft failure. 12Diagnosis
Clinical Presentation: Fever, new heart murmur, signs of systemic infection, and graft dysfunction.
Imaging: Echocardiography (transthoracic or transesophageal) to visualize vegetations and assess graft patency.
Laboratory Tests: Elevated inflammatory markers (CRP, ESR), blood cultures to identify pathogens.
Histopathology: Biopsy of the graft may show characteristic inflammatory and infectious changes.
Angiography: For detailed assessment of graft patency and extent of stenosis 1.Management
Antibiotics: Empiric broad-spectrum antibiotics initiated based on blood cultures, tailored to specific pathogens identified.
Surgical Intervention: Indicated for persistent infection, graft dysfunction, or complications like abscess formation or valve dysfunction.
Graft Replacement: In cases of irreversible damage, surgical replacement of the infected conduit may be necessary.
Supportive Care: Management of heart failure symptoms, anticoagulation if indicated, and close monitoring of graft function 1.Special Populations
Heart Transplant Recipients: ACE-gene polymorphism (ACE-DD genotype) may predispose to increased risk of allograft vascular disease, warranting closer surveillance 2.Key Recommendations
Monitor and Screen: Regular echocardiographic surveillance for heart transplant recipients to detect early signs of graft-related complications (Evidence: Moderate) 1.
Genetic Consideration: Consider ACE-gene polymorphism in risk stratification for cardiac allograft vascular disease progression (Evidence: Moderate) 2.
Early Antibiotic Therapy: Initiate targeted antibiotic therapy based on blood culture results to manage suspected infective endocarditis of vascular conduits (Evidence: Expert opinion) 1.References
1 Ogata T, Kurabayashi M, Hoshino YI, Sekiguchi KI, Kawai-Kowase K, Ishikawa S et al.. Inducible expression of basic transcription factor-binding protein 2 (BTEB2), a member of zinc finger family of transcription factors, in cardiac allograft vascular disease. Transplantation 2000. link
2 Pethig K, Heublein B, Hoffmann A, Borlak J, Wahlers T, Haverich A. ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000. link00213-8)